DT Investment Partners’s ResMed RMD Stock Holding History

DT Investment Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.24K	Hold	32	–	–	﹤0.01%	431
2026 Q1	$7.18K	Hold	32	–	–	﹤0.01%	420
2025 Q4	$7.71K	Hold	32	–	–	﹤0.01%	442
2025 Q3	$8.76K	Hold	32	–	–	﹤0.01%	420
2025 Q2	$8.26K	Hold	32	–	–	﹤0.01%	424
2025 Q1	$7.16K	Hold	32	–	–	﹤0.01%	446
2024 Q4	$7.32K	Sell	32 -105	-77%	-$25.3K	﹤0.01%	448
2024 Q3	$33.4K	Buy	137 +32	+30%	+$7.15K	﹤0.01%	298
2024 Q2	$20.1K	Buy	+105	New	+$21.3K	﹤0.01%	309
2023 Q1	–	Sell	-13	Closed	-$2.71K	–	497
2022 Q4	$2.71K	Hold	13	–	–	﹤0.01%	436
2022 Q3	$3K	Buy	+13	New	+$2.96K	﹤0.01%	407

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

DT Investment Partners's RMD Position: Q2 2026 in Review

DT Investment Partners held its ResMed (RMD) position steady in Q2 2026 at 32 shares worth $6.24K. The position accounts for ﹤0.01% of the portfolio, ranked #431.

DT Investment Partners first reported a position in RMD in Q3 2022 and has held it in 11 quarters since. The position peaked at $33.4K in Q3 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

DT Investment Partners held 32 shares of ResMed worth $6.24K as of Q2 2026.
DT Investment Partners left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of DT Investment Partners's portfolio in Q2 2026, its #431 holding.
DT Investment Partners first reported a position in ResMed in Q3 2022 and has held it in 11 quarters since.
DT Investment Partners's ResMed position peaked at $33.4K in Q3 2024.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.